Belysse Group NV
SWB:BDB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Belysse Group NV
SWB:BDB
|
BE |
|
PCC Exol SA
F:9B2
|
PL |
|
I
|
Inspire IVF PCL
SET:IVF
|
TH |
|
Asuransi Bina Dana Arta Tbk PT
IDX:ABDA
|
ID |
|
S
|
Sabre Gold Mines Corp
XMUN:7AZ
|
CA |
|
P
|
Phio Pharmaceuticals Corp
NASDAQ:PHIO
|
US |
|
DP Poland PLC
LSE:DPP
|
UK |
|
Alterity Therapeutics Ltd
F:PBN0
|
AU |
|
SolarWindow Technologies Inc
OTC:WNDW
|
US |
|
CEMATRIX Corp
TSX:CEMX
|
CA |
|
Australian Industrial Minerals Ltd
ASX:AAM
|
AU |
Wall St Price Targets
BDB Price Targets Summary
Belysse Group NV
According to Wall Street analysts, the average 1-year price target for BDB is 1.546 EUR with a low forecast of 1.531 EUR and a high forecast of 1.592 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BDB's stock price target?
Price Target
1.546
EUR
According to Wall Street analysts, the average 1-year price target for BDB is 1.546 EUR with a low forecast of 1.531 EUR and a high forecast of 1.592 EUR.
What is the Revenue forecast for Belysse Group NV?
Projected CAGR
1%
Over the last 4 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Belysse Group NV?
Projected CAGR
5%
Over the last 4 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for Belysse Group NV?
Projected CAGR
9%
Over the last 4 years, the compound annual growth rate for Operating Income has been -13%. The projected CAGR for the next 3 years is 9%.
